Related Experiment Videos
Altered urinary excretion of human kininase activity in acute myocardial infarction
Insights
Human urinary kininase activity is significantly reduced in acute myocardial infarction (AMI) patients compared to healthy individuals. This enzymatic reduction may indicate a potential biomarker for diagnosing AMI.
Area of Science:
- Biochemistry
- Cardiology
- Urology
Background:
- Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
- Urinary enzyme excretion patterns can reflect systemic physiological changes.
- Kininase and kallikrein are enzymes involved in the kallikrein-kinin system.
Purpose of the Study:
- To determine human urinary kininase excretion levels in patients with acute myocardial infarction (AMI).
- To compare urinary kininase activity in AMI patients versus normal individuals.
- To investigate the potential of urinary kininase as a biomarker for AMI.
Main Methods:
- A biological assay was employed to measure enzymatic activity.
- Urinary samples were collected from patients diagnosed with AMI and healthy controls.
- Quantification of bradykinin destruction was used to assess kininase activity.
Main Results:
- A significant reduction in urinary kininase enzymatic activity was observed in AMI patients (6.4 +/- 0.4 ng/min) compared to normal individuals (164.4 +/- 31.4 ng/min).
- The difference in enzymatic activity between the two groups was statistically significant (P < 0.001).
- Urinary kallikrein excretion levels were found to be near normal in AMI patients.
Conclusions:
- Urinary kininase excretion is markedly decreased in individuals experiencing acute myocardial infarction.
- This reduction in enzymatic activity suggests urinary kininase may serve as a potential diagnostic indicator for AMI.
- Further research is warranted to validate urinary kininase as a reliable biomarker for cardiac events.
Abstract:
This study concerns the determination of levels of human urinary kininase excretion in acute myocardial infarction (AMI). The results obtained by a biological method show that there is a significant reduction of the enzymatic activity in patients affected by AMI in comparison with normals (6.4 +/- 0.4 ng of destroyed bradykinin/min. versus 164.4 +/- 31.4 ng; P less than 0.001), while urinary kallikrein excretion was close to normal values.